14. Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P; QUARTETStudy Group. A long-term comparison of pioglitazone and gliclazide in patients with type 2 diabetes mellitus: a randomized,double-blind, parallel-group comparisontrial. Diabet Med 2005;22:399 –405 15. DeFronzo RA, Okerson T, Viswanathan P, Guan X, Holcombe JH, MacConell L. Ef-fects of exenatide versus sitagliptin onpostprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric in- take: a randomized, cross-over study. CurrMed Res Opin 2008;24:2943 –2952 16. Pratley RE, Nauck M, Bailey T, et al. Liraglutide versus sitagliptin for patientswith type 2 diabetes who did not have ade-quate glycemic control with metformin: a 26- week, randomised, parallel-group, open- label trial. Lancet 2010;375:1447 –1456 17. Diamant M, Van Gaal L, Stranks S, et al. Once weekly exenatide compared with insulin glargine titrated to target in pa-